Clinical Trial Update: Ferric Carboximaltose on Intra-myocardial Iron Load in Patients With Heart Failure [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating ferric carboxymaltose effect on intra-myocardial iron load in patients with heart failure with a focus on systolic heart failure.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiac Failure
• Heart Failure
• Systolic Heart Failure

Drugs mentioned

• Ferric Carboximaltose (ferric carboximaltose)

Snippet

Sponsor: Hospital Moinhos de Vento | Conditions: Cardiac Failure, Systolic Heart Failure | Phase 4 | Status: UNKNOWN